NOS3 and neoplasm: They then analyzed the model under different VEGF concentrations that resembled actual VEGF levels present in the tumor microenvironment and evaluated the therapeutic potential of several new intracellular targets/processes in terms of shutting down VEGF‐induced pro‐angiogenic activation of eNOS and cGMP.